Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Pfizer, Moderna and Gilead reputations climb on COVID-19 vaccine and treatment news, according to Harris Poll
Fierce Pharma
Mon, 08/10/20 - 12:14 pm
Pfizer
Gilead Sciences
Moderna Therapeutics
vaccines
reputation
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Pharmaforum
Fri, 08/7/20 - 11:11 am
Pfizer
Gilead Sciences
remdesivir
COVID-19
pandemic
drug manufacturing
Gilead's COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents
Fierce Pharma
Wed, 08/5/20 - 11:14 pm
Gilead Sciences
remdesivir
COVID-19
FDA
NIH
HHS
drug pricing
Covid-19 treatment: Gilead Sciences urged to study drug that showed promise with cats
The Guardian, UK
Wed, 08/5/20 - 12:05 am
GS-441524
Gilead Sciences
Public Citizen
COVID-19
remdesivir
Gilead Sciences' Revenue and Earnings Slip in Second Quarter
Motley Fool
Thu, 07/30/20 - 11:21 pm
Gilead Sciences
earnings
Go or no go? Valuable drugs set for FDA decisions
EP Vantage
Wed, 07/29/20 - 10:54 am
FDA
drug approvals
Novartis
inclisiran
Biomarin
valrox
Roche
risdiplam
GSK
belantamab mafodotin
Gilead Sciences
Galapagos
filgotinib
Gilead’s Kite gains some height after second CAR-T approval in US
Pharmaforum
Tue, 07/28/20 - 10:57 am
Gilead Sciences
Kite Pharma
CAR-T
Gilead’s Kite Pharma gets FDA nod for second CAR-T cell therapy
MedCity News
Sat, 07/25/20 - 02:29 pm
Gilead Sciences
CAR-T
KTE-X19
Tecartus
FDA
Kite Pharma
Gilead-partnered Glympse snares $46.7M for their NASH-snooping biosensors
Endpoints
Wed, 07/15/20 - 10:18 am
Glympse Bio
NASH
Gilead Sciences
Here's Gilead Sciences' Great COVID-19 Opportunity That You'll Really Want to Watch
Motley Fool
Tue, 07/14/20 - 10:36 am
Gilead Sciences
remdesivir
COVID-19
From Houston to Miami, hospitals running short of remdesivir for Covid-19 patients
Stat
Mon, 07/13/20 - 11:36 pm
Gilead Sciences
remdesivir
pandemic
COVID-19
Biopharma takeovers show quantity, if not quality
EP Vantage
Mon, 07/13/20 - 11:13 am
COVID-19
pandemic
M&A
Novo Nordisk
Corvidia
Gilead Sciences
Pionyr
Alexion
Portola Pharmaceuticals
Menarini
Stemline Therapeutics
Shionogi
Tetra Therapeutics
Why Gilead Sciences' Successful COVID-19 Results Fell Flat
Motley Fool
Sun, 07/12/20 - 11:14 pm
Gilead Sciences
COVID-19
pandemic
remdesivir
Stocks Cut Losses After Gilead Says Remdesivir Coronavirus Treatment Reduces Risk Of Death
Forbes
Fri, 07/10/20 - 11:04 am
Gilead Sciences
pandemic
remdesivir
clinical trials
COVID-19
Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds
MedCity News
Fri, 07/10/20 - 10:49 am
Gilead Sciences
remdesivir
NIH
COVID-19
5 FDA approval decisions to watch in the 3rd quarter
BioPharma Dive
Thu, 07/9/20 - 11:09 am
FDA
Gilead Sciences
filgotinib
rheumatoid arthritis
GSK
belantamab mafodotin
Multiple Myeloma
NS Pharma
viltolarsen
Duchenne Muscular Dystrophy
Gilead Testing Inhaled Form Of Remdesivir That Could Be Used To Treat Covid-19 Outside Hospital
Forbes
Thu, 07/9/20 - 12:07 am
Gilead Sciences
remdesivir
COVID-19
pandemic
clinical trials
Biotech Gilead axes $445M Precision Biosciences gene therapy hep B pact
Fierce Biotech
Wed, 07/8/20 - 10:39 am
Gilead Sciences
Precision Biosciences
hepatitis B
R&D
GSK sets the stage for a toe-to-toe market showdown with Gilead's HIV champion Truvada
Endpoints
Wed, 07/8/20 - 10:38 am
GSK
Gilead Sciences
ViiV Healthcare
HIV
cabotegravir
Truvada
New Data Shows Promise Involving Lenacapavir for the Treatment of HIV
BioSpace
Thu, 07/2/20 - 11:30 pm
Gilead Sciences
lenacapavir
HIV
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »